10 ML Tyenne 20 MG/ML Injection
- RxCUI
- 2679441
- RxNorm name
- 10 ML Tyenne 20 MG/ML Injection
- Display name
- 10 ML Tyenne 20 MG/ML Injection
- Full name
- 10 ML Tyenne 20 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761275 | Tyenne | tocilizumab-aazg | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | e400bbe6-43c5-4de6-82b9-cb44ce3cd906 | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | 2679441 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e400bbe6-43c5-4de6-82b9-cb44ce3cd906 | Tyenne 200 MG in 10 ML Injection [PSN] · 10 ML tocilizumab-aazg 20 MG/ML Injection [Tyenne] [SBD] · 10 ML Tyenne 20 MG/ML Injection [SY] · Tyenne 200 MG per 10 ML Injection [SY] | 4 | 2 | These highlights do not include all the information needed to use TYENNE safely and effectively. See full prescribing information for TYENNE. TYENNE ® (tocilizumab-aazg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2024 TYENNE ® (tocilizumab-aazg) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful d | 20241230 |